Anti-Human LGR4 VHH (SAA2295) from ProteoGenix; catalogue ARO-A23021; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Are you looking for a cutting-edge biotech product that can revolutionize your research? Look no further than Anti-Human LGR4 VHH (SAA2295), a highly specific and potent antibody designed to target the Leucine-rich repeat-containing G protein-coupled receptor 4 (LGR4).
LGR4 is a transmembrane protein that plays a crucial role in various physiological processes, such as embryonic development, tissue regeneration, and cell proliferation. Dysregulation of LGR4 has been linked to several diseases, including cancer, making it an attractive target for therapeutic interventions.
Anti-Human LGR4 VHH (SAA2295) is specifically designed for use in biotech research, with a focus on LGR4-related diseases. Its unique binding properties make it an ideal tool for studying LGR4 function and regulation, as well as for screening potential therapeutic agents.
This powerful antibody has been extensively tested and validated in various experimental settings, including Western blot, immunohistochemistry, and flow cytometry. Its high specificity and sensitivity allow for accurate and reliable detection of LGR4, even in complex biological samples.
Why Choose Anti-Human LGR4 VHH (SAA2295)?
In conclusion, Anti-Human LGR4 VHH (SAA2295) is a game-changing biotech product that offers unparalleled specificity and versatility for studying LGR4 and its associated diseases. Trust in its proven performance and take your research to the next level. Order now and unlock the full potential of biotechnology.
ProteoGenix catalogue number ARO-A23021. For research use only.
Target: G-protein coupled receptor 48, GPR48, LGR4, Leucine-rich repeat-containing G-protein coupled receptor 4; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
